Additionally, IGFBP-2 is upregulated in several cancers and promotes several pathways involved in oncogenic signaling, including the stimulation of proliferation, epithelial–mesenchymal transition, invasion, metastasis, and angiogenesis, all of which are independent of IGF-1 [46,47]. The gene discussed is IGF1; the disease is cancer.